Read our news

At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.

On the occasion of the first National Bioproduction and Biomedicine Day, which took place on the last 5th july, we were very proud to welcome a TVR journalist in our Javené site for an exclusive report.

We are delighted to announce that HTL Biotechnology has once again been awarded the EcoVadis Gold 2024 label for its Corporate Social Responsibility (CSR) performance!

BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage.

HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow (Nutley, NJ). Notably, this acquisition includes Modern Meadow’s platform of recombinant proteins, with the most advanced product being human recombinant collagen type III (rhCOL3).

As every year, the In-Cosmetics Global Congress returns to Paris, with top industry leaders and experts gathering under one roof.
This event promises opportunities and insights into the future of Cosmetics.

France BioLead structures, pilots, supports and promotes the French biomanufacturing sector.

AMWC, the Aesthetic & Anti-Aging Medicine World Congress in Monaco.

PCHi is an annual gathering of professionals from the cosmetics and aesthetics industry, featuring formulators, manufacturers and R&D experts from all over the world. 

Discussion between Ted Lain, American dermathologist and François Fournier about the key role played by HTL Biotechnology in aesthetic medicine.

The 35th edition of CIBE in Guangzhou attracted over 3,500 companies, covering various sectors such as cosmetics, personal care, beauty equipment and health products.

Dubai Derma, the leading Dermatology & Laser Event in the Middle East, Africa Market, and Beyond.